Glympse Bio is pioneering the development of synthetic biomarkers – biological sensors developed using breakthroughs in science, engineering, medicine and artificial intelligence – that are bioengineered to be perfectly tunable to any disease, absolutely specific, and offer earlier measures of response to disease and treatment.

Medical Devices

Glympse Bio

Glympse Bio's headquarters in Cambridge, MA, United States

Dhaval Gosalia

Jonathan Wilde

Raynie Smith

Waylon Parham

Rohit Loomba

Amy Schulman

George Zachary

Theresia Gouw

Steve Kafka

Francis Cuss

Richard B. Lanman

Stanley Lapidus

Scott Friedman

Sangeeta Bhatia

Arun Sanyal

Gyongyi Szabo

Robert S. Langer

Charles S. Craik

The Strategy and Operations Team at Glympse Bio is responsible for driving the company's strategic initiatives and optimizing operational processes to enhance efficiency and innovation. This team collaborates across departments to align goals, manage projects, and support decision-making, ensuring that the development of synthetic biomarkers is executed seamlessly and effectively in pursuit of transformative advancements in disease diagnosis and treatment.

Strategy and Operations Team

The Leadership Team at Glympse Bio is responsible for setting the strategic vision and direction of the company, ensuring alignment across all departments in the pursuit of developing innovative synthetic biomarkers. Comprising experts in strategy, science, finance, and human resources, the team collaborates to drive operational excellence, foster research and development, and build a culture that supports the company's mission to revolutionize disease monitoring and treatment response.

Leadership Team

The Clinical Advisors Team at Glympse Bio is responsible for guiding the research and development of synthetic biomarkers, ensuring they align with clinical needs and regulatory standards. This team collaborates with scientists and engineers to refine biomarker applications, evaluates clinical trial designs, and translates complex scientific concepts into actionable insights for healthcare practitioners, ultimately enhancing early disease detection and treatment response.

Clinical Advisors Team

The Research and Development team at Glympse Bio focuses on advancing the creation of synthetic biomarkers by leveraging cutting-edge science, engineering, and AI. The team conducts rigorous research and experimentation to synthesize and analyze these biomarkers, ensuring they are highly specific and adaptable to various diseases. Their efforts are crucial for enabling earlier detection and response measurement for patients, ultimately enhancing treatment outcomes.

Research and Development

The Scientific and Research Team at Glympse Bio conducts cutting-edge research to develop and refine synthetic biomarkers for various diseases. Leveraging expertise in biology, medicine, and artificial intelligence, the team collaborates to enhance the specificity and tunability of these biomarkers, enabling earlier and more accurate measures of disease response and treatment efficacy. Through innovative research initiatives, they drive the company's mission to revolutionize disease detection and management.

Glympse Bio

Org chart

Board & advisors

Teams

Strategy and Operations Team

Leadership Team

Clinical Advisors Team

Research and Development

Scientific and Research Team

Offices

Glympse Bio

Org chart

Board & advisors

Teams

Strategy and Operations Team

Leadership Team

Clinical Advisors Team

Research and Development

Scientific and Research Team

Offices

Related companies